Fenwick & West advised DICE Therapeutics on the deal. DICE Therapeutics (Nasdaq: DICE), a biopharmaceutical company leveraging its proprietary technology platform to build a pipeline of...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised RTW Investments on the deal while Fenwick & West represented Lycia Therapeutics. Lycia Therapeutics, Inc., a leader in extracellular protein...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati and Fenwick & West advised DiCE Molecules on the deal. DiCE Molecules, a biopharmaceutical company leveraging its proprietary DNA-encoded library platform...
You must be a Standard 1 Year member to access this content.
Fenwick & West LLP advised Gupshup on the deal. Gupshup, a leader in conversational messaging, announced its follow-on funding of $240 million from an industry-leading group of...
You must be a Standard 1 Year member to access this content.
Vedder Price is serving as legal counsel to Zebra. Fenwick & West is acting as legal counsel and Evercore is acting as financial advisor to Fetch....
You must be a Standard 1 Year member to access this content.
Fenwick & West LLP advised Brightline on the deal. Brightline, the first comprehensive behavioral health solution built specifically to care for children, teens, and their families...
You must be a Standard 1 Year member to access this content.
Fenwick & West LLP advised UserLeap on the deal. UserLeap has designed a platform aimed at allowing product managers to personalize customer surveys and present them...
You must be a Standard 1 Year member to access this content.
